**GENERIC SPECIALS - DEEP DISCOUNTS **
"Weekly Generics Campaign"
LOOK for DEEP Discounts with APCI's Weekly Generics Campaign!
Regular ordering through McKesson - discount price will be in place during campaign period.
Items on the Generics Campaign this week:
Effective for orders placed 7/09/15 – 07/15/15
ITEM# |
NDC |
DESC |
TOP 250 |
CAMPAIGN DATES |
INVOICE DATES |
1398288 |
228277811 |
PROPRAN ER 60MG |
N |
7/16/15 - 7/22/15 |
7/17/15 -7/23/15 |
1913391 |
168016246 |
CLOBETA PR OI 0.05% |
N |
7/16/15 - 7/22/15 |
7/17/15 -7/23/15 |
1432905 |
16714036304 |
TRI-LN TB.18MG/.035MG6X28 |
N |
7/16/15 - 7/22/15 |
7/17/15 -7/23/15 |
1396282 |
603243321 |
BENZTROP TB 0.5MG 100 |
N |
7/16/15 - 7/22/15 |
7/17/15 -7/23/15 |
Antipyrine Otic was previously scheduled for this week’s campaign has since been removed from the formulary due to vendor not able to supply – sorry for the loss of this product – our sourcing team is working to get a replacement soon!
2481539 ANTIPYRINE OTIC SOL B&L 10ML@ not on campaign
Watch for these Items on Generics Campaign NEXT week:
ITEM# |
NDC |
DESC |
TOP 250 |
CAMPAIGN DATES |
INVOICE DATES |
2156743 |
55111025660 |
ZIPRASID CAP 20MG |
N |
7/23/15 - 7/29/15 |
7/24/15 - 7/30/15 |
1139781 |
781502207 |
METHYLPRED TAB 4MG |
Y |
7/23/15 - 7/29/15 |
7/24/15 - 7/30/15 |
2026979 |
55111053405 |
DIVALPROEX ER 500MG |
Y |
7/23/15 - 7/29/15 |
7/24/15 - 7/30/15 |
2028371 |
65862056090 |
PANTOPRAZOL DR 40MG 90 |
Y |
7/23/15 - 7/29/15 |
7/24/15 - 7/30/15 |
1890805 |
49884060511 |
LAMOTRIG ER TAB 300MG PAR 30@ |
N |
7/23/15 - 7/29/15 |
7/24/15 - 7/30/15 |
Check out a full list of Custom Discounted Items our website weekly - updated every Monday!
https://www.apcinet.com/AboutUs/Services/VendorContracting/APCIDiscountedGenerics/tabid/535/Default.aspx
|
NEWS YOU CAN USE
|
Generic Launches
Launch of generic Namenda® IR
Amneal launched the generic equivalent of Namenda IR (memantine HCl). The Amneal items will be added to the APCI Formulary program in the A-slot, with visibility in McKesson Connect Saturday, July 11, 2015. Estimated U.S. brand sales of Namenda IR are approximately $2.8B.
There will be an ASAP/ASAP+ for this launch. ASAP+ shipments will begin next week and be completed by Monday, July 20th.
Product Launch Information – OneStop Add |
Bx Name |
Namenda IR |
Bx Supplier |
Actavis |
Generic Name |
memantine HCl |
Generic Description |
2 strengths – 5mg and 10mg Tablets |
Therapeutic Class/Indication |
289200-CENTRAL NERVOUS SYSTEM AGENTS, MISC. / indicated for the treatment of moderate to severe dementia of the Alzheimer's type. |
FDA Approval Date |
4/10/2015 |
Launch Reason |
Settlement |
Launch Exclusivity |
No |
Number of Players |
4+ |
US Brand Sales |
$2.8B |
To order, please use the following item numbers:
Item # |
Supplier Name |
NDC |
Description |
OS ADD |
3468139* |
AMNEAL PHARMACEUTICALS |
53746016930 |
MEMANTINE HCI TAB 10MG AMN 30 |
07/11/2015 |
3468121 |
AMNEAL PHARMACEUTICALS |
53746017360 |
MEMANTINE HCI TAB 5MG AMN 60 |
07/11/2015 |
*Please note, the 10mg generic item launched as a 30-count bottle, rather than a 60-count bottle.
**We want to be sure customers are aware you will be receiving your price protected ASAP+ shipments so that you do not proactively purchase inventory before the shipments arrive.
Launch of Generic Targretin®
Mylan launched the generic equivalent of Targretin Capsules® (bexarotene). The Mylan item will be added to the OneStop program in the A slot, with visibility in McKesson Connect on Friday, July 10, 2015. Estimated U.S. brand sales of Targretin are approximately $10M. There will be NOT be ASAP & ASAP+ for this launch.
Product Launch Information – Formulary Add |
Bx Name |
Targretin Capsules |
Bx Supplier |
Valeant |
Generic Name |
bexarotene |
Generic Description |
75 mg 100 count |
Indication |
Treatment of cutaneous manifestations of cutaneous T-cell lymphoma in patients who are refractory to at least one prior systemic therapy. |
FDA Approval Date |
8/12/2014 |
Launch Reason |
Settlement |
Launch Exclusivity |
Yes |
Number of Players |
1 |
US Brand Sales |
$10M |
To order, please use the following item numbers:
Item # |
Supplier Name |
NDC |
Description |
OS ADD |
3466307 |
MYLAN PHARMACEUTICALS |
00378695501 |
BEXAROTENE CAP 75MG MYL 100 |
7/10/2015 |
For questions please contact ISManagement@McKesson.com.
Launch of Generic Axert®
Patriot launched the generic equivalent of Axert® (almotriptan malate). The Patriot item will be added to the APCI Formulary program in the A slot, with visibility in McKesson Connect on Wednesday, July 8, 2015. Estimated U.S. brand sales of Axert® are approximately $51M.
To order, please use the following item numbers:
Item # |
Supplier Name |
NDC |
Description |
MS ADD |
3459799 |
PATRIOT PHARMACEUTICALS |
10147096101 |
ALMOTRIP MAL TB 12.5MG PAT 2X6 |
07/08/2015 |
3459773 |
PATRIOT PHARMACEUTICALS |
10147096201 |
ALMOTRIP MAL TB 6.25MG PAT 1X6 |
07/08/2015 |
For questions please contact ISManagement@McKesson.com
Service Level Watchlist
Watchlist as of July 12, 2015
SL Item |
Item |
NDC |
Description |
Supplier |
OS Slot |
Update |
AZITHROMYCIN |
|
2046845 |
63739057510 |
AZITHROMY TAB 250MG UD SKY100@ |
SKY PHARMACEUTICAL |
A |
NO RELEASE DATE |
BENZONATATE |
* |
3247475 |
65162053710 |
BENZONATATE CAP 200MG AKY 100@ |
AMNEAL/AKYMA PHARMA |
A |
PRODUCT AVAILABLE |
|
1340934 |
65162053750 |
BENZONATATE CP 200MGAMN 500@ |
AMNEAL/AKYMA PHARMA |
A |
NO RELEASE DATE |
BUPROPION HCL |
* |
1806314 |
185111160 |
BUPROPIO ER TAB 200MG SAN 60@ |
SANDOZ PHARMACEUTICALS |
A |
AVAILABLE LATE JULY 2015 |
* |
1204577 |
185041560 |
BUPROPIO ER TB 150MG SAN 60@ |
SANDOZ PHARMACEUTICALS |
A |
AVAILABLE LATE JULY 2015 |
|
2137446 |
47335073886 |
BUPROPIO ER TAB 200MG CARA 60@ |
CARACO PHARMACEUTICALS |
A/C |
AVAILABLE LATE JULY 2015 |
|
1257542 |
185041501 |
BUPROPIO
ER TAB 150MG EON 100@ |
SANDOZ
PHARMACEUTICALS |
A |
AVAILABLE
EARLY AUGUST 2015 |
|
1439405 |
185041552 |
BUPROPIO
ER TAB 150MG SAN 250@ |
SANDOZ
PHARMACEUTICALS |
A |
AVAILABLE
LATE JULY 2015 |
|
1215128 |
185041505 |
BUPROPIO
ER TAB 150MG SAN 500@ |
SANDOZ
PHARMACEUTICALS |
A |
AVAILABLE
LATE JULY 2015 |
|
2137370 |
47335073788 |
BUPROPIO
ER TB 150MG CARA 100@ |
CARACO
PHARMACEUTICALS |
A/C |
AVAILABLE
IN LIMITED QUANTITY IN LIMITED DCs |
|
2137354 |
47335073786 |
BUPROPIO
ER TAB 150MG CARA 60@ |
CARACO
PHARMACEUTICALS |
A/C |
AVAILABLE
IN LIMITED QUANTITY IN LIMITED DCs |
|
2137495 |
47335073713 |
BUPROPIO
ER TB 150MG CARA 500@ |
CARACO
PHARMACEUTICALS |
A/C |
AVAILABLE
IN LIMITED QUANTITY IN LIMITED DCs |
CYCLOBENZAPRINE HCL |
* |
1149483 |
50111056301 |
CYCLOBENZ
TAB 10MG TEVA 100@ |
TEVA
PHARMACEUTICALS |
A |
TO
BE DISCONTINUED |
|
1361955 |
50111056303 |
CYCLOBENZ
TAB 10MG TEVA 1000@ |
TEVA
PHARMACEUTICALS |
A |
TO
BE DISCONTINUED |
DICYCLOMINE HCL |
* |
1979467 |
378162001 |
DICYCLOM
TAB 20MG MYL 100@ |
MYLAN
PHARMACEUTICALS |
A |
AVAILABLE
LATE JULY 2015 |
EPINEPHRINE |
* |
1990654 |
54505010202 |
EPINEPH
INJ 0.3MG AMED 2@ |
AMEDRA
SPECIALTY GX (FORMERLY CORE) |
A |
AVAILABLE
EARLY AUGUST 2015 |
|
2580157 |
54505010201 |
EPINEPH
AUTO INJ 0.3MG AMED@ |
AMEDRA
SPECIALTY GX (FORMERLY CORE) |
A/C |
AVAILABLE
EARLY AUGUST 2015 |
ETHOSUXIMIDE |
* |
3219359 |
61748002501 |
ETHOSUX
CAP 250MG VERS 100@ |
VERSAPHARM
INC |
A |
AVAILABLE
EARLY AUGUST 2015 |
FELODIPINE |
* |
1399252 |
53489036901 |
FELODIP
ER TAB 5MG MUT 100@ |
MUTUAL/SCH |
A |
AVAILABLE
LATE JULY 2016 |
FLUOXETINE HCL |
* |
2474674 |
93718856 |
FLUOXET
TAB 10MG TEV 30@ |
TEVA
PHARMACEUTICALS |
A |
AVAILABLE
LATE JULY 2015 |
|
3000346 |
93718810 |
FLUOXET
HCL TAB 10MG TEV1000@ |
TEVA
PHARMACEUTICALS |
A |
AVAILABLE
IN LIMITED DCs |
HYDROCHLOROTHIAZIDE |
* |
2058584 |
16729018201 |
HYDROCHL
TAB 12.5MG ACC 100@ |
ACCORD |
A |
AVAILABLE
IN LIMITED QUANTITY |
KETOCONAZOLE |
* |
1641919 |
781709004 |
KETOCONAZOLE
SHAM 2% SAN 4OZ@ |
SANDOZ
PHARMACEUTICALS |
A |
AVAILABLE
LATE JULY 2015 |
LITHIUM CARBONATE |
* |
2106961 |
68462022401 |
LITHIUM
CARB ER 450MG GLEN100@ |
GLENMARK
PHARMACEUTICALS |
A |
AVAILABLE
LATE JULY 2015 |
|
2065332 |
68084065501 |
LITHIUM
TAB 450MG UD AHP 100@ |
AMERICAN
HEALTH PACKAGING |
A |
NO RELEASE
DATE |
LOPERAMIDE HCL |
* |
1622117 |
93031101 |
LOPERAM
CAP 2MG TEV 100@ |
TEVA
PHARMACEUTICALS |
A |
AVAILABLE
LATE JULY 2015 |
|
1622232 |
93031105 |
LOPERAM
CAP 2MG TEV 500@ |
TEVA
PHARMACEUTICALS |
A |
AVAILABLE
MID AUGUST 2015 |
MIRTAZAPINE |
|
1254663 |
63739035610 |
MIRTAZAP
TAB 30MG UD SKY10X10@ |
SKY
PHARMACEUTICAL |
A |
NO
RELEASE DATE |
MUPIROCIN CALCIUM |
* |
1902840 |
66993094215 |
MUPIROCIN
CM 2% PRAS 15G@ |
PRASCO
LABORATORIES |
A |
AVAILABLE
LATE JULY 2015 |
TAMOXIFEN CITRATE |
* |
1106681 |
378027493 |
TAMOXIFEN
CITR TB 20MG MYL 30@ |
MYLAN
PHARMACEUTICALS |
A |
AVAILABLE
LATE JULY 2015 |
|
1112879 |
378027401 |
TAMOXIFEN
CITR TB 20MG MYL100@ |
MYLAN
PHARMACEUTICALS |
A |
TO
BE DISCONTINUED |
TEMAZEPAM |
|
1254960 |
63739023110 |
TEMAZEP
CAP 15MG UD SKY 10X10@ |
SKY
PHARMACEUTICAL |
A |
AVAILABLE
IN LIMITED DCs |
TRAMADOL HCL |
* |
3209277 |
49884082111 |
TRAMADOL
ER TAB 100MG PAR 30@ |
PAR
PHARMACEUTICAL INC |
A/C |
AVAILABLE
MID JULY 2015 |
VENLAFAXINE HCL |
* |
2135010 |
93738456 |
VENLAF
ER CP 37.5MG TEV 30@ |
TEVA
PHARMACEUTICALS |
A/C |
AVAILABLE
LATE AUGUST 2015 |
|
3436797 |
904646861 |
VENLAF
ER CP UD37.5MGMMP10X10@ |
MAJOR
PHARMACEUTICAL |
A/C |
AVAILABLE
IN LIMITED DCs |
|
2151934 |
59762018003 |
VENLAF
ER CP37.5MG UDGRE10X10@ |
GREENSTONE
LIMITED |
A/C |
AVAILABLE
IN LIMITED DCs |
Drug Supply Chain Security Act
The Drug Supply Chain Security Act (DSCSA) was signed into law on November 27, 2013, as Title II of the Drug Quality and Security Act of 2013. DSCSA creates national requirements for tracing pharmaceuticals across the supply chain, preempting any state-level requirements associated with the Prescription Drug Marketing Act of 1987. This includes provisions for product identification, tracing and verification, detection and response, notification, wholesaler licensing, and third-party logistics provider licensing.
DSCSA provides consistency of traceability on a national scale. Full implementation within the next 10 years will result in standardized, unit-level traceability from the manufacturer to the pharmacy/practitioner – the entire supply chain.
Upcoming DSCSA milestones include:
January 1, 2015
- All suppliers must send to McKesson: transaction history (TH), transaction information (TI), and transaction statement (TS) data for all pharmaceutical products. McKesson must provide this transaction record data to its customers. All customers which function as distributors must do the same for their respective customers.
- All customers are responsible for monitoring/reporting any suspect/illegitimate products in the supply chain.
July 1, 2015
- McKesson Distribution Center (DC) Purchases: McKesson will retain customer data for purchases from McKesson Distribution Centers for six years.
- Non-McKesson DC Purchases: Pharmacies must begin retaining TH, TI and TS data for six years.
Please contact your McKesson Sales Representative if you have questions or need additional information regarding DSCSA.
To run the Traceability reports in Connect go to:
Business Management Programs > Reports > Traceability Reporting >
Enter Account information and other data to run the report
|
APCI APPROVED VENDORS
|